Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years

INTRODUCTION: Data from clinical studies on the long-term efficacy and safety of anti-tumor necrosis factor (TNF)-α therapy in patients with ankylosing spondylitis (AS) are scarce. This is the first report on continuous treatment with the TNFα fusion protein etanercept over seven years (y). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Baraliakos, Xenofon, Haibel, Hildrun, Fritz, Claudia, Listing, Joachim, Heldmann, Frank, Braun, Juergen, Sieper, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060369/
https://www.ncbi.nlm.nih.gov/pubmed/23786760
http://dx.doi.org/10.1186/ar4244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060369/
https://www.ncbi.nlm.nih.gov/pubmed/23786760
http://dx.doi.org/10.1186/ar4244

Ejemplares similares